Cover
Cover | Nov. 22, 2019 |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 22, 2019 |
Entity File Number | 001-37539 |
Entity Registrant Name | Global Blood Therapeutics, Inc. |
Entity Central Index Key | 0001629137 |
Entity Tax Identification Number | 27-4825712 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 171 Oyster Point Blvd., Suite 300 |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | 650 |
Local Phone Number | 741-7700 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | GBT |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |